We have previously shown that lysates from HL-60 myeloid leukemia cells or from peripheral blood monocytes are able to degrade aactinin to form a 31-kDa amino-terminal fragment with monocyte/macrophage maturation promoting activity. In contrast, intact a-actinin, which is a 100-kDa actin-binding protein, has no differentiating activity. The aim of this study was to investigate the enzyme responsible for the degradation of a-actinin to form this fragment, named mactinin. The ability of cell lysates to degrade [
Introduction
Hematopoietic cell maturation is known to be a highly regulated process in which a small population of primitive cells mature in the bone marrow microenvironment. The microenvironment is a complex reservoir of bioactive substances including growth factors, growth factor inhibitors [1, 2] , adhesion molecules [3] , and matrix-degrading enzymes [4] . Regulation of the proteolytic activity in the pericellular environment appears to be a primary mechanism by which leukocyte function and the course of inflammation are regulated [5] .
We have shown that a 31-kDa fragment from the aminoterminal end of a-actinin, which was initially isolated from bone marrow stromal cultures, can promote monocyte/ macrophage maturation of HL-60 myeloid leukemia cells, U-937 histiocytic lymphoma cells, and peripheral blood monocytes [6] . Alpha-actinin is a cytoskeletal protein present in a variety of cells and tissues [7] [8] [9] and one of many actin binding proteins found in focal adhesion sites, where cells attach to extracellular matrix (ECM) [10] . Focal adhesion sites contain several proteins that are synthesized and laid down during contact between cells and their substratum [11] . We also have shown that a-actinin is abundant in the bone marrow stroma matrix, presumably at focal adhesion sites, and reduced in the presence of HL-60 myeloid leukemia cells [12] . Furthermore, lysates of HL-60 cells or of peripheral blood monocytes degrade the inactive 100-kDa a-actinin to produce the 31-kDa fragment, which we have named mactinin, which can induce a mature macrophage phenotype [12] . That is, we have demonstrated that mactinin significantly increases lysozyme secretion and tartrate-resistant acid phosphatase staining in peripheral blood monocytes.
In the present study, we investigated the enzyme responsible for mactinin formation by using various common protease inhibitors. These included inhibitors of (a) metalloproteinases, a family of enzymes that degrade most ECM components [13] , (b) cysteine proteinases including lysosomal cathepsins [14] , and (c) serine proteases, including thrombin, plasmin, and urokinase-type plasminogen activator, which degrade fibrin and ECM proteins [15] . The results of enzyme inhibition studies, the ability of exogeneous urokinase to form the active fragment, and its presence in HL-60 cell lysates suggest that urokinase is responsible for the formation of mactinin in vitro.
To determine whether urokinase modulates mactinin formation during inflammatory responses in vivo, we examined bronchoalveolar lavage fluid (BAL) from mice after intratracheal challenge with the opportunistic pathogen Pneumocystis carinii. Previous studies showed that uPA (urokinase) knockout mice [16] demonstrate reduced inflammatory cell recruitment and are susceptible to P. carinii, in contrast to wild-type mice which mount inflammatory responses to P. carinii and clear the infection [17] . Consistent with our in vitro data, mactinin was present in the BAL fluid of wild-type mice during clearance of infection, but was absent in the uPA knockout mice despite progressive P. carinii infection. These results indicate that urokinase also mediates mactinin formation in vivo.
Materials and methods

Chemicals
Alpha-actinin, EDTA, phenylmethylsulfonyl fluoride (PMSF), N-ethylmaleimide (NEM), 1,10 phenanthroline, trans-epoxysuccinyl-L-leucylamido (4-guanidino) butane (E-64), N a -p-tosyl-L-lysine chloromethyl ketone (TLCK), N-p-tosyl-L-phenylalanine chloromethyl ketone (TPCK), peptostatin, thrombin, plasmin, amiloride, and aprotinin were purchased from Sigma (St. Louis, MO). Urokinase was purchased from Calbiochem (San Diego, CA).
Alpha-actinin radiolabeling
One milligram of chicken gizzard a-actinin in phosphate buffer (0.1 M KH 2 PO 4 , pH 8) was incubated with 250 ACi [ 125 I]Bolton-Hunter reagent (NEN-Dupont, Boston, MA; specific activity 4400 Ci/mmol) according to the manufacturer's instructions. Radiolabeled a-actinin was then isolated on a PD-10 column and found to have a specific activity of approximately 1.6 Â 10 5 cpm/Ag.
Cell culture
An adherent bone marrow stroma cell line previously established in this laboratory [18] from a normal volunteer donor was grown to confluence in tissue culture flasks (Nunc, Naperville, IL) containing RPMI-1640 supplemented with 15% heat-inactivated fetal calf serum, and 50 Ag/ml gentamicin (GIBCO, Green Island, NY). After 6 days in stationary culture, the adherent layer was washed with PBS, exposed to 1% Triton X-100 (vol/vol) for 30 min at room temperature, and subsequently washed with PBS to remove most remaining cell nuclei and cytoskeletal elements from ECM-coated flasks [19] . HL-60 cells (1 Â 10 5 /ml) were seeded on matrix-coated flasks and grown for 3 days in RPMI media with 15% FCS and 50 Ag/ml gentamicin. We have previously reported that HL-60 cells grown on this matrix demonstrate a more mature morphology, increased nonspecific esterase, activity, and increased ability to form Fc rosettes [18] . Conditioned media (CM) was harvested by removing the media, centrifuging at 200 Â g for 4 min, and collecting the supernatant.
Cell lysate preparation
Although lysates of control HL-60 cells, of mature HL-60 cells grown on matrix, and of blood monocytes can each degrade a-actinin to form the 31-kDa fragment [12] , we elected to use HL-60 cells grown on matrix for the inhibition experiments. HL-60 cells grown on matrix (1.5 -2 Â 10 6 ) were detached by exposure to 2 mM EDTA for 3 min at 37 jC followed by gentle pipetting. Suspension and detached cells were combined, washed with PBS, then lysed at 4 jC with 100-ml lysis buffer (1% Triton X-100, 50 mM TrisCl, 5 mM CaCl 2 , pH 7.8) and stored at À 20 jC until the time of analysis. 6 cells) in the absence or presence of various enzyme inhibitors for 2 h at 37 jC. Enzyme inhibitors included 25 mM EDTA, 1 mM 1, 10 phenanthroline, 10 AM E-64, 2 mM NEM, 0.1 mM PMSF, 50 Ag/ml TLCK, 100 Ag/ml TPCK, and 1 Ag/ml peptostatin. Samples were then loaded on a 12% SDSpolyacrylamide gel and electrophoresed. Gels were dried on a gel dryer (Model 583, Bio-Rad, Hercules, CA) and exposed to X-ray film (Kodak, Rochester, NY) with an intensifying screen at À 70 jC. Densitometry measurements of the 31-kDa fragment and 100-kDa a-actinin were performed using a Power Look scanner (UMAX, Hsinchu, Taiwan) and NIH Image Software.
Enzyme digestion of [
125 I] a-actinin by selected serine proteases
5 cpm) was incubated with various serine proteases at 37 jC. Thrombin and plasmin were used at an enzyme/substrate ratio 1:10 for 2 h in 0.1 M TrisCl digestion buffer, pH 8.0. Urokinase was used at 4000 Plough units at 37 jC in 0.1 M TrisCl digestion buffer pH 8.0, for 18 h. Samples were then electrophoresed on a 12% SDS-polyacrylamide gel. The gel was then dried and autoradiography was performed as previously described.
Electroelution
From a companion lane of the SDS-polyacrylamide gel containing the products of urokinase digestion of 10-Ag unlabeled a-actinin, a 31-kDa band corresponding to that detected by autoradiography or by silver staining was excised and placed in dialysis tubing (Spectrum, Houston, TX). Electroelution was carried out at 35 mA for 16 h in 192 mM glycine and 25 mM TrisCl. Samples were then dialyzed against H 2 O and concentrated by a vacuum evaporator (Savant, Farmingdale, NY) to a volume suitable for in vitro maturation assays (less than 100 Al).
Assessment of maturation
As previously described for maturation assays [6] , HL-60 cells were seeded at a density of 1 Â 10 5 /ml and grown for 3 days in the presence of the urokinase-generated 31-kDa degradation product of a-actinin that had been separated by SDS-PAGE and electroelution. Maturation of HL-60 cells was determined, as measured by nonspecific esterase activity [20] and Fc rosette formation [21, 22] .
Measurement of urokinase activity
Urokinase activity was measured using the chromogenic substrate S-2444 (Chromogenix, Mölndal, Sweden). Cell lysates from 2 Â 10 6 HL-60 cells grown on plastic or matrix or CM from HL-60 cells grown on plastic or matrix and concentrated using an M r 10,000 Centricon membrane were each incubated with aprotinin (10 KIU/ml) for 1 h to block nonspecific protease activity. Samples were then incubated with 3 mM S-2444 substrate, 50 mM TrisCl, 38 mM NaCl, pH 8.8 for 5 min. The reaction was stopped with 2% acetic acid. The optical absorbance was read at 405 nm with a spectrophotometer (Beckman, Fullerton, CA) and urokinase activity was estimated from a standard curve generated with commercially prepared urokinase (Calbiochem, La Jolla, CA).
Inhibition of a-actinin degradation by cell lysate with amiloride
Amiloride specifically inhibits urokinase activity [23] . Lysate from 1 Â 10 6 HL-60 cells was incubated with amiloride (final concentration 2.5 mM) for 30 min at 37 jC then incubated with [
125 I]a-actinin for 2 h at 37 jC and loaded on an SDS-polyacrylamide gel.
2.11. Inflammatory BAL fluid from uPA knockout and wildtype mice Transgenic uPA-deficient mice (uPA À / À ) and background matched control mice (wild-type) were generous gifts from Dr. Peter Carmeliet. These mice were developed as previously described [16] . Genotype of the uPA knockout mice was confirmed by PCR analysis as described previously [24] . Groups of uPA knockout mice and wild-type mice were intratracheally inoculated with 1 Â 10 5 P. carinii organisms, obtained from the lungs of chronically infected C57BL/6 scid mice as previously described [17] . Two weeks after inoculation, mice were exsanguinated during deep pentobarbital anesthesia. A polyethylene catheter was inserted into the trachea and the lungs were lavaged with 11-ml PBS in 0.5-ml aliquots. Fluids from individual mice were centrifuged at 500 Â g to remove cells and the supernatants were frozen at À 80 jC until analyzed. These animal studies were approved by the Animal Care Committee, Ann Arbor Veterans Affairs Medical Center.
Source of mactinin for antibody production
A pGEX2 vector, encoding the actin-binding domain, residues 2 -269 of chicken smooth muscle a-actinin, fused with the C terminus of glutathione S-tranferase (GST) with an engineered thrombin cleavage site, was kindly provided by Dr. D.R. Critchley of the University of Leicester, UK. Fusion protein was expressed in E. coli and purified by affinity chromatography of cell extracts on immobilized glutathione. The fusion protein was then cleaved with thrombin to yield the actin-binding domain of a-actinin and the GST carrier. The cleavage products were dialyzed against 50 mM TrisCl, pH 7.5, then renatured in 5 mM glutathione, and separated on a reverse phase HPLC C-4 column. The column was equilibrated with 0.1% trifluoroacetic acid and eluted with a 30-70% acetonitrile gradient run at 1%/ml/min. Fractions eluting at 50 -60% acetonitrile contained the fragment as demonstrated by silver-stained SDS-PAGE of the fractions and confirmed by Western blot analysis using polyclonal antisera raised against 100-kDa chicken a-actinin. The a-actinin fragment was >90% of the total protein of pooled fractions with the remaining 10% being carrier GST. The calculated molecular weight of this a-actinin fragment was 30,700 Da, and this recombinant fragment had monocyte/macrophage maturation-promoting activity as measured by nonspecific esterase staining of treated HL-60 myeloid leukemia cells. Mactinin and GST were routinely assayed for protein endotoxin using a Pyrotell chromogenic assay kit (Associates of Cape Cod, Woods Hole, MA). If detected, endotoxin was removed using endotoxin removal affinity resin.
Antisera generation
Antisera with sensitivity for detecting mactinin were generated in rabbits with approval of the IACUC of the Minneapolis Veterans Affairs Medical Center. Briefly, purified recombinant chicken a-actinin peptide was modified by dinitrophenol coupling and injected into two New Zealand white rabbits along with complete Freund's adjuvant. Boosts were done with peptide and incomplete Freund's adjuvant. Antisera were screened for ability to detect the immunizing peptide and immunoaffinity-purified using columns of the recombinant fragment covalently bound to an Affi-Gel 15 Matrix (Bio-Rad). We anticipated cross-reactivity of the purified antisera with fragments from rats, mice, or humans due to the highly conserved amino acid sequence.
Results
The serine protease inhibitor PMSF inhibits the generation of the 31-kDa a-actinin fragment by cell lysate
Monocytes and macrophages produce many secretory products [25] and contain various proteases, which may play important roles in modulating ECM [26] . We hypothesized that mature HL-60 cells, like monocytes, produce an enzyme which is responsible for a-actinin degradation. To test this hypothesis we examined the effect of various enzyme inhibitors on degradation of radiolabeled a-actinin by mature HL-60 cell lysates using SDS-PAGE. Although different lysates and different samples of radiolabeled aactinin varied in the extent of uninhibited degradation, the effect of the inhibitors was reproducible. Metalloproteinases are an important group of enzymes produced by mononuclear cells [27] to degrade ECM [28] , and their secretion is altered during cell differentiation. EDTA and 1,10 phenanthroline are both inhibitors of metalloproteinases, but neither showed inhibition of cell lysate degradation of a-actinin (Fig. 1) . We further tested the cysteine proteinase inhibitors, NEM and E-64. Again, as shown in Fig. 1 , formation of the 31-kDa fragment was not inhibited. We then tested various serine protease inhibitors, including PMSF, TLCK, TPCK, and peptostatin. As shown in Fig. 2 , PMSF was the only inhibitor to inhibit the formation of a 31-kDa degradation product. This suggests that the active enzyme in the cell lysate is a serine protease.
Urokinase digests a-actinin to produce a 31-kDa band
Serine proteases are a large group of enzymes which are present in vivo and include coagulation factors, plasminogen activators, plasmin, thrombin, subtilisin, trypsin, propardin, pronase, kallikrein, endopeptidases, chymotrypsin, and complement factor-1. We elected to test some of the more physiologically relevant of these enzymes for aactinin degradation. Fig. 3 shows the results of incubating [ 125 I]a-actinin with various serine proteases. Although thrombin and plasmin were able to degrade a-actinin, only urokinase was able to produce a 31-kDa a-actinin fragment.
Urokinase-generated 31-kDa a-actinin fragment induces HL-60 cell maturation
Degradation products of a-actinin digestion by urokinase were separated by SDS-PAGE, and the 31-kDa band was electroeluted and tested for maturation-promoting activity using the HL-60 cell line. Fig. 4 shows the induction of two markers of monocyte/macrophage maturation, Fc rosette formation and esterase staining. The electroeluted 31-kDa band had maturation promoting activity similar to that of 12-0-tetradecanoylphorbol-13-acetate (TPA), a strong inducer (positive control).
Mature HL-60 cells release urokinase activity
HL-60 cells grown on bone marrow matrix express a mature macrophage-like phenotype [18] . Lysates of these cells and CM from these cultures were tested for urokinase activity. As shown in Table 1 , lysate of mature HL-60 cells grown on matrix contained urokinase activity, as did CM from cultures on matrix. In contrast, lysates of HL-60 cells grown on plastic or CM from these cultures contained no detectable urokinase activity ( < 2 IU), suggesting that urokinase activity increases with maturation. After 72 h of culture, HL-60 cells grown on plastic or bone marrow matrix were harvested. Concentrated CM and cell lysate from 2 Â 10 6 cells were incubated with 10 KIU/ml aprotonin for 1 h to block nonspecific protease activity, then assayed for urokinase activity using the S-2444 substrate and the acid stop method per manufacturer's instructions.
The urokinase inhibitor, amiloride, inhibits the generation of the active 31-kDa a-actinin fragment
To further confirm that urokinase is the enzyme in HL-60 cell lysates responsible for the formation of the active aactinin fragment, cell lysates from 2 Â 10 6 mature HL-60 cells were incubated with a-actinin in the presence or absence of amiloride. Amiloride, a diuretic drug, inhibits urokinase activity, but does not affect tissue-type plasminogen activator, plasmin, plasma kallikrein, or thrombin [23] . As shown in Fig. 5 , amiloride effectively inhibited the formation of the 31-kDa band.
Mactinin is absent in inflammatory fluid from uPA knockout mice
Affinity-purified rabbit antiserum raised against a recombinant chicken a-actinin fragment detects picogram amounts of the immunizing peptide. As shown in Fig. 6 , this antiserum reacts with a protein of the expected molecular weight in mouse BAL fluid. BAL fluid from 6 of 8 wildtype mice challenged intratracheally with P. carinii demonstrated mactinin bands. In contrast, BAL fluid from 0 of 8 infected uPA knockout mice challenged intratracheally with P. carinii demonstrated detectable fragment, despite progressive infection ( P < 0.01 by Fisher's exact test). To ensure that mactinin formation depended upon the inflammatory response, BAL fluid from 4 wild-type and 4 uPA knockout mice that were not challenged with P. carinii was tested for mactinin. None was detected [data not shown].
Discussion
Regulation of cell maturation by the microenvironment
Hematopoeitic cell maturation is a complex process in which cells mature in close contact with the ECM. This process is regulated by signals from various cell adhesion molecules and is influenced by various cytokines and peptides [1] [2] [3] . Not only is the ECM considered a source of regulatory signals for maturation, but in turn, cells ]a-actinin. The degradation products were then subjected to SDS-PAGE followed by autoradiography. Fig. 6 . Western blot analysis using affinity-purified antisera raised against the recombinant chicken a-actinin fragment. In the mouse, the calculated molecular weight of the fragment is 820 Da more than in the chicken or 31.8 kDa. Lanes A -H each contain 0.7-ml BAL fluid from wild-type mice challenged intratracheally with P. carinii during clearance of infection. Lanes I -P contain 0.7-ml BAL fluid from uPA knockout mice challenged intratracheally with P. carinii during progressive infection. The last row contains recombinant chicken fragment in the amount shown. Two bands appear due to an alternate thrombin cleavage site in the fusion protein.
modify the ECM by secreting various products which function to degrade and remodel it [4] . This interaction between cells and their microenvironment is felt to be important in immunity, inflammation, and homeostasis [29 -31] .
We previously reported that CM from HL-60 cells grown on bone marrow ECM induces monocyte/macrophage-like maturation of other HL-60 cells [18, 32] . We isolated a 31-kDa fragment of a-actinin, now named mactinin, from this CM which was able to promote macrophage maturation of various cells, including U-937 histiocytic lymphoma cells, and peripheral blood monocytes [6] . We also have shown that a-actinin is abundant in the bone marrow ECM at focal adhesion sites where cells are in close contact with their substratum [12] . The present work focused on the potential mechanism through which mactinin, the maturation-promoting a-actinin fragment, is formed.
Urokinase degrades a-actinin to form mactinin in vitro
Alpha-actinin is a 100-kDa actin-binding protein found at focal contact sites [10] . Cell lysates of HL-60 cells or peripheral blood monocytes are able to degrade inactive 100-kDa a-actinin into the active 31-kDa fragment [12] , suggesting that the lysates contain an enzyme(s) which degrades a-actinin. Using various enzyme inhibitors, we now show that a serine protease is likely to be responsible for this degradation. Of the various serine proteases tested, urokinase was able to degrade a-actinin to produce a 31-kDa fragment with differentiating activity. Furthermore, the urokinase specific inhibitor, amiloride, inhibited the formation of this fragment by HL-60 cell lysates. Indeed, urokinase activity was secreted by mature HL-60 cells.
Urokinase activity in inflammation
The expression of urokinase activity is intimately involved in the course of inflammatory responses [33] . For example, in the mouse excisional wound model, urokinase activity increases during the healing process, then returns to undetectable baseline levels by the time of wound closure [34] . The expression of urokinase is also up-regulated in macrophages cultured on ECM [35] , and levels of urokinase and other proteases serve as useful markers of macrophage activation [36] . This supports our finding that mature HL-60 cells grown on ECM contain more urokinase activity than control HL-60 cells.
Urokinase is thought to play a central role in regulating extracellular proteolysis in a variety of normal and pathological processes involving tissue destruction and cell migration [37, 38] . Of note, endothelioma cells [39] and macrophages [16] from urokinase knockout mice display reduced ability to degrade extracellular matix. Many cells that secrete urokinase also express specific high-affinity plasma membrane binding receptors (u-PAR) [40, 41] which bind urokinase to allow localized proteolytic activity. These receptors may also protect urokinase from enzyme inhibition [42] . The urokinase-like plasminogen activator and its receptor is the most thoroughly known and studied cell surface proteolytic system [43] . This system has been shown to be directly involved in several steps of tumor cell invasion [44, 45] and in inflammatory responses [46] . It appears, from studies of animals with targeted inactivation of various fibrinolytic genes, that urokinase alone, without the urokinase receptor or tissue-type plasminogen activator, is sufficient to support the tissue remodeling of wound repair [47] .
Urokinase degradation of extracellular proteins
When peripheral blood monocytes adhere to the stroma or endothelial cells, they cause retraction or movement [48] at the leading edge, uncovering focal adhesion sites which become directly accessible for degradation by enzymes such as urokinase [49] . This retraction or movement is also accompanied by increased membrane permeability, which may allow the release of high molecular weight intracellular proteins [48] . Both urokinase and urokinase receptors are localized at focal adhesion sites [50] . Previous investigators have shown that urokinase receptors bind to vitronectin and integrin at distinct sites from urokinase binding to form a stable complex [51 -55] . Thus, integrin may facilitate interaction between urokinase and cytoskeletal proteins such as a-actinin at focal adhesion sites. These enzyme/receptor/ substrate complexes may allow proteolysis to occur at a high enzyme/substrate ratio [56] .
The proteolytic degradation of various ECM proteins by other members of the plasminogen activator system is well established [57, 58] . For example fibronectin is digested by thrombin to yield two large and one small fragments [59] . A fragment of fibronectin was shown to induce the expression of stromalysin mRNA and cause chondrocyte chondrolysis [60] . Also, plasmin activated by urokinase binds and degrades several components of the ECM, including fibronectin, laminin, and proteoglycan [61, 62] .
Urokinase is required for mactinin formation in vivo
Mactinin's absence in inflammatory fluid from uPA (urokinase) knockout mice is consistent with the results of our in vitro studies that show that urokinase is necessary for mactinin formation. Our findings may have broad physiological relevance in any inflammatory process in which urokinase and macrophages play essential roles [63] . The urokinase knockout mice have deficient macrophage recruitment in response to infection [17] and other inflammatory conditions [64] . We have recently demonstrated that mactinin, in addition to promoting monocyte/macrophage maturation, is chemotactic for monocytes [unpublished data]. Although mactinin may be a unique regulator of monocyte/ macrophage response to infection and inflammation, it may not be absolutely necessary for normal response, as it was not detectable in two of the wild-type mice. We are currently investigating how mactinin interacts with monocytes to signal maturation.
